the cancer epidemic, risk assessment and the...

55
The cancer epidemic, risk assessment and the requirement for precaution Dr. C. Vyvyan Howard FRCPath. Developmental Toxico-Pathology University of Liverpool [email protected]

Upload: phungtruc

Post on 11-Apr-2018

222 views

Category:

Documents


5 download

TRANSCRIPT

Page 1: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

The cancer epidemic, risk assessment and the requirement

for precaution

Dr. C. Vyvyan Howard FRCPath.Developmental Toxico-Pathology

University of [email protected]

Page 2: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

The Precautionary Principle

• "When an activity raises threats of harm to human health or the environment, precautionary measures should be taken, even if some cause and effect relationships are not fully established scientifically"‘Wingspread Statement on Chemically-Induced Alterations to immune system.’ Environmental Health Perspectives, 104:4, August 1996.

Page 3: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Risk Assessment

• The main tool used to hinder the implementation of the Precautionary Principle

• Used as ‘proof’ that technologies are safe• Often accepted as hard proof, even when

based on questionable data models

Page 4: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Risk assessment was designed by engineers to assess the reliability of engineered structures, where most of the facts are known or can be measured.

Page 5: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Risk Assessment –Invented by Engineers

• Used to assess the integrity of structures• Most information required is available• Realistic risk assessments possible• Lead to over design of structures

– Bridges and buildings typically x 5– Aircraft typically x 1.1 to 1.2The tighter the margin – more research required

Page 6: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Risk Assessment – 4 phases

• Hazard identification – requires insight and understanding of the system in question

• Hazard assessment – costs time and money for hard science – positive findings require action

• Exposure assessment – can be very expensive and, for human exposure, complex

• Risk assessment – depends totally on the 1st three steps

Page 7: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Risk assessment in engineeringis not foolproof

• Despite sophisticated models based on hard data and years of experience unpredictable events still happen

• This represents either a failure of hazard identification or of hazard assessment

Page 8: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •
Page 9: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •
Page 10: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Complex Systems

• Risk assessment is now being applied to very complex systems - such as ecosystems

• It is impossible to have comprehensive hazard data for such systems

• Missing data is often provided by ‘data models’, but these can be subjective

• Sometimes the whole risk assessment can be based solely upon data models

Page 11: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •
Page 12: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

BATNIEC vs CATNIP

• Best Available Technology Not Involving Excessive Cost

• Cheapest Available Technology Not Involving Prosecution

• However in risk assessment it could be: Confusing Alternative Theory Not Involving the Producer

Page 13: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Possibilities for investigation

• Man made: e.g. chemicals, radionuclides, particulate aerosols, etc.

• Lifestyle: e.g. smoking, eating, sedentarism, choosing the wrong parents, etc

• Nature: e.g. sun spot activity, volcanoes etc

Page 14: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

0

50

100

150

200

Cas

es/m

illio

n C

hild

ren

1975

1985

1995

Cancer Incidence and Mortality Trends For Children Under 20 in USA (1974-98)

Mo rt a l i t y

Inc ide nc e

Page 15: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •
Page 16: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

0

100

200

300

400

500

600

1960 1970 1980 1985 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000

Inci

denc

era

te/1

04

AustraliaAustriaBelgiumCanadaCzech RepublicDenmarkFinlandGermanyGreeceHungaryItalyLuxembourgMexicoNetherlandsNew ZealandNorwayPolandSlovak RepublicTurkeyUnited KingdomUnited States

Page 17: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Xeno-chemical exposure

• During the period of rapid rise in incidence of cancer we have been exposed to a complex mixture of novel chemicals, some genotoxic, some acting as cancer promoters.

• This toxicity of this mixture, consisting of 10’s of thousands of congeners, enantiomers and metabolites, is beyond the current ability of toxicologists to analyse

Page 18: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Evidence of presence of rapidly metabolised compounds

Page 19: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Evidence of the presence of persistent xeno-chemicals

Page 20: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •
Page 21: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •
Page 22: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

The developmental process is both sensitive and vulnerable

Page 23: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Human Reproduction VoLl6, No.5 pp. 972-978, 2001

OPINION

Testicular dysgenesis syndrome: an increasingly commondevelopmental disorder with environmental aspects------------------------------------------------------------------------------N.E.Skakkebrek1, E.Rajpert-De Meyts and K.M.Main

Department of Growth and Reproduction, Copenhagen University Hospital, Copenhagen, Denmark1To whom correspondence should be addressed at: Department of Growth and Reproduction, Copenhagen University Hospital(Rigshospitalet, Section GR-5064), 9 Blegdamsvej, DK-2100 Copenhagen, Denmark. E-mail: [email protected]

Numerous reports have recently focused on various aspects of adverse trends in male reproductive health, such asthe rising incidence of testicular cancer; low and probably declining semen quality; high and possibly increasingfrequencies of undescended testis and hypospadias; and an apparently growing demand for assisted reproduction.Due to specialization in medicine and different ages at presentation of symptoms, reproductive problems used tobe analysed separately by various professional groups, e.g. paediatric endocrinologists, urologists, andrologists andoncologists. This article summarizes existing evidence supporting a new concept that poor semen quality, testiscancer, undescended testis and hypospadias are symptoms of one underlying entity, the testicular dysgenesissyndrome (TDS), which may be increasingly common due to adverse environmental influences. Experimental andepidemiological studies suggest that TDS is a result of disruption of embryonal programming and gonadaldevelopment during fetal life. Therefore, we recommend that future epidemiological studies on trends in malereproductive health should not focus on one symptom only, but be more comprehensive and take all aspects of msinto account. Otherwise, important biological information may be lost.

Keywords: environmental disrupters/inferti1ity/male reproduction/testicular cancer/ testicular development

Page 24: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •
Page 25: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •
Page 26: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Exposure to ionising radiation

• We have been exposed to external ionising radiation throughout evolution

• Since the start of atmospheric weapons testing we have been exposed to novel sources of radiation in the form of internalised particles of radioactive material

• This has happened over the same period during which there has been a rapid rise in cancer incidence

Page 27: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •
Page 28: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Elements migrate from sea to land

• It turns out that in the UK, 30% of the smallrespirable particles in the air of less than 10 microns diameter (known as PM10) come from the action of the waves, which produce small droplets of water that then evaporate and leave a suspended crystal of salt, which remains airborne. Scientists have been aware since 1984 that radioactive actinides have been coming ashore by this mechanism. Eakins JD, Lally AE (1984) ’The transfer to land of actinide bearing sediments from the Irish Sea by spray’ Science of the Total Environment 35: 23-32

Page 29: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •
Page 30: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •
Page 31: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Plutonium across the UK

Page 32: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Plutonium in teeth

Page 33: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Plutonium in autopsy specimens

Page 34: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Of Risk Assessment..

• A former director of the US EPA said:

• “We should remember that risk assessment can be likened to the captured spy: if you torture it long enough, it will tell you anything you want to know”

Page 35: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

ICRP Phantom

Page 36: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

External vs Internal Radiation

ICRP model averages radiation dose into the body volume

When ‘hot particles’ are internalised they intensely irradiate a very small volume

Averaging the radiation from low dose internalised radionuclides is clearly an inconsistent model.

Page 37: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Depleted uranium particle doses

Page 38: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Absorbed dose

• D = −E / −M

• −E energy in Joules• −M mass in Kilos• Unit: Gray (Gy)• 100 Rads = 1 Gy

• ICRP fundamental dosimetric quantity is the absorbed dose (energy absorbed per unit mass).

• However different radiations have differing ionisation densities

Page 39: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Equivalent dose

• The choice of these WR factors can be subjective and are made by committees such as the ICRP.

• Very conservative assumptions can be used to justify the status quo ante

• HT = ;R WR DT,R

• HT:equivalent dose, H, in tissue, T.

• DT,R:absorbed dose averaged over tissue

• WR:radiation weighting factor

• Unit: Sievert (1 Sv ≈ 100 rem)

Page 40: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

ICRP radiation weighting factors

Type of radiation WR

X- and Κradiation, all energies

1

ϑ particles 1

Ι particles 20

Neutrons & protons

5 to 20

• In 1980s ICRP considered applying WR factors of 2 for Tritium and 5 for Auger emitters (e.g. Ba-140), but made no changes.

• Relative biological effectiveness (RBE) is the inverse ratio of absorbed doses (Ι,ϑ,Κ) producing the same degree of a defined biological endpoint. WRroughly equivalent to Linear Energy

Transfer (LET) along ionisation track

Page 41: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

ECRR approach

• This approach takes the properties of individual isotopes into account. E.g. Strontium 90 ( a divalent ion) binds to chromosomes and then decays to Ytrium 90 (a trivalent ion) which bioaccumulates

• BT,E=;R NE HT,R• BT,E :Biological equivalent dose• NE :Hazard enhancement

weighting factor

• NE = ; WJ WK• WJ biophysical hazard factors• WK isotope biochemical hazard

factors

Page 42: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Table 6.2 from ECRR 2003 – ISBN: 1 897761 24 4

Biophysical hazard factors in low dose range

Type of exposure Factor WJ Notes1. External acute 1.0

2. External protracted 1.0 Dose rate sparing is not assumed

3. External: 2-hits in 24 hrs 10 to 50 Allows for repair interception

4. Internal atomic single decay 1.0 e.g. Potassium-40

5. Internal atomic 2nd Event 20 to 50 Depends on decay sequence and dose

6. Internal Auger or Coster-Kronig

1 to 100 Depends on location and energy

7. Internal insoluble particulate 20 to 1,000 Depends on activity , particle size and dose

Page 43: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Table 6.3. ECRR 2003: Specific isotope hazard enhancement factors

Isotope or class Factor WK Mechanism of enhacement3-H, Tritium 10 to 30 Transmutation & local dose;

hydrogen bonding; enzyme amplifyIonic equilibria cations e.g. K,Cs,Ba,Sr,Zn

2 to 10 Local conc. By interfacial ionic adsorption; depends on effect

DNA binding e.g. Sr, Ba, Pu

10 to 50 DNA primary, secondary and tertiary structure disruption

14-C 5 to 20 Transmutation and enzyme amplification

35-S, 132-Te 10 Transmutation and enzyme amplification; hydrogen bonding

Enzyme & co-enzyme seekers e.g. Zn,Mn,Co,Fe

10 Enzyme amplification

Fat soluble noble gases e.g. Ar-41, Kr-85

2 to 10 Depends on effect considered

Barrier transmutation series e.g. Sr-90, Y-90

2 to 1,000 Depends on effect considered

Page 44: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Table 13.3 from ECRR 2003 – ISBN: 1 897761 24 4Based on Table 58 of UNSCEAR 1993 and ECRR model effective dose committment

Source of exposure ICRP based collective effective dose commitment (person Sieverts)

ECRR based collective effective dose commitment (person Sieverts), using UNSCEAR isotope proportions

Global nuclear tests 22,300,000 579,800,000

Weapons fabrication 10,000 260,000

Nuclear power production 100,000 2,600,000

Radioisotope production 80,000 8,000,000

Accidents 602,120 15,655,120

Local & regional doses 380,000 9,880,000

Total 23,472,120(b4.7 mSv)

616,195,120(b123 mSv)

b based on world population of 5 x 109 assumed by UNSCEAR

Page 45: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Table 13.4 from ECRR 2003 – ISBN: 1 897761 24 4Based on UNSCEAR figures up to 1989

Effect ICRP yield ECRR yield

Cancer deaths 1,173,606 61,619,500

Cancer totals 2,350,000 123,239,000

Infant deaths 0 160,000,000

Fetal deaths 0 188,000,000

Loss of life quality

0 10%

Page 46: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Leukaemia RRs• Sellafield RR=10• Dounreay RR= 8• La Hague RR= 15

• Electrical field studies RR~ 2• Population mixing RR~ 1.5 - 2

Page 47: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Infant leukaemia after Chernobyl

Page 48: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •
Page 49: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •
Page 50: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

The Nordic leukaemia studyDarby et al, 1993

Page 51: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Danish cancer registry leukaemia data

Page 52: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Effect of the Nevada tests

Page 53: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Conclusions 1

• Cancer incidence rates are increasing overall and for a number of individual malignancies, including leukaemia

• There have been man made chemical and radiological changes to the environment which are completely novel from an evolutionary perspective and preceded these changes

Page 54: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Conclusions 2

• The biological plausibility for associating these changes with the rise in cancer is strong

• The complexity of human exposure to multiple factors in a disease which is acknowledged to be multi-causal makes one to one mappings of cause and effect very difficult or impossible

Page 55: The cancer epidemic, risk assessment and the …cwl2004.powerwatch.org.uk/programme/speakers/day5-howard-pres.pdf · The cancer epidemic, risk assessment and the requirement ... •

Conclusions 3

• There can be little reasonable argument that exposure of the population to carcinogens should be avoided

• In the absence of scientific certainty a precautionary stance should be adopted to minimise exposure by removing sources